Table 6 Experimental data for the synthesis of salicylaldehydes and free ligands
Compounds
Starting materials
Yield
1H NMR (CDCl3)
3-tert-Butyl-5-
isopropyl-
salicylaldehyde
2-Isopropyl-4-tert-butylphenol
(9.62 g, 50.0 mmol), parafor-
maldehyde (4.50 g, 150 mmol)
9.47 g, 43.0 mmol, 86.0%
d 1.24 (d, J = 6.9 Hz, 6H, CHMe2), 1.30 (s, 9H, CMe3),
1.33 (s, 9H, CMe3), 3.38 (h, J = 2.4 Hz, 1H, CHMe2),
7.05 (d, J = 2.4 Hz, 1H, PhH), 7.24 (d, J = 2.4 Hz, 1H,
PhH), 9.86 (s, 1H, CHO), 11.46 (s, 1H, OH)
d 1.31 (s, 9H, CMe3), 1.78 (s, 6H, Ad–CH2), 2.07 (s, 3H,
Ad–CH), 2.16 (s, 6H, Ad–CH2), 7.10 (s, J = 2.4 Hz, 1H,
PhH), 7.29 (s, J = 2.4 Hz, 1H, PhH), 9.88 (s, 1H, CHO),
11.52 (s, 1H, OH)
d 1.31 (d, 6H, CHMe2), 1.45 (s, 9H, CMe3), 3.55 (h, J =
6.3 Hz, 1H, CHMe2), 6.82 (t, J = 7.5 Hz, 1H, PhH), 7.13
(t, J = 7.5 Hz, 1H, PhH), 7.33 (t, J = 7.5 Hz, 1H, PhH),
8.37 (s, 1H, CH N), 14.18 (s, 1H, OH)
d 1.25 (d, J = 6.9 Hz, 6H, CHMe2), 1.31 (s, 9H, CMe3),
1.34 (s, 9H, CMe3), 3.40 (h, J = 2.4 Hz, 1H, CHMe2),
7.09 (d, J = 2.4 Hz, 1H, PhH), 7.29 (d, J = 2.4 Hz, 1H,
PhH), 8.34 (s, 1H, CH N), 14.52 (s, 1H, OH)
d 1.28 (d, J = 6.9 Hz, 6H, CHMe2), 1.33 (s, 9H, CMe3),
1.80 (s, 6H, Ad–CH2), 2.10 (s, 3H, Ad–CH), 2.19 (s, 6H,
Ad–CH2), 3.51 (m, J = 6.3 Hz, 1H, CHMe2), 7.14 (s, J =
2.4 Hz, 1H, PhH), 7.34 (s, J = 2.4 Hz, 1H, PhH), 8.38 (s,
1H, CH N), 13.90 (s, 1H, OH)
3-Admantyl-5-tert-
butyl-salicylaldehyde
2-Adamantyl-4-tert-butylphenol
(14.2 g, 50.0 mmol), parafor-
maldehyde (4.50 g, 150 mmol)
12.7 g, 40.6 mmol, 81.3%
2.14 g, 9.62 mmol, 96.2%
2.66 g, 9.51 mmol, 95.1%
3.25 g, 9.20 mmol, 92.0%
HL2
HL4
HL6
3-tert-Butylsalicylaldehyde
(1.78 g, 10.0 mmol), isopro-
pylamine (1.20 g, 20.0 mmol)
3-Isopropyl-5-tert-butyl-
salicylaldehyde (2.20 g, 10.0 mmol),
tert-butylamine (1.46 g, 20.0 mmol)
3-Admantly-5-tert-butyl-
salicylaldehyde (3.13 g, 10.0 mmol),
isopropylamine (1.20 g, 20.0 mmol)
Table 7 Experimental data for the synthesis of complexes 2–6
Complex
Starting materials
Yield
Elemental analyses
2
HL2 (0.439 g, 2.00 mmol), n-BuLi (1.60 M,
2.05 mmol), Cp*Li (0.284 g, 2.00 mmol),
CrCl3(THF)3 (0.750 g, 2.00 mmol)
0.527 g, 1.20 mmol,
60.2%
Calcd for C24H33NOCrCl (438.97): C 65.67; H 7.58; N 3.19.
Found: C 65.40; H 7.64; N 3.12.
3
4
5
6
HL3 (0.469 g, 2.00 mmol), n-BuLi (1.60 M,
2.05 mmol), Cp*Li (0.284 g, 2.00 mmol)
and CrCl3(THF)3 (0.750 g, 2.00 mmol)
HL4 (0.551 g, 2.00 mmol), n-BuLi (1.60 M,
2.05 mmol), Cp*Li (0.284 g, 2.00 mmol)
and CrCl3(THF)3 (0.750 g, 2.00 mmol)
HL5 (0.551 g, 2.00 mmol), n-BuLi (1.60 M,
2.05 mmol), Cp*Li (0.284 g, 2.00 mmol)
and CrCl3(THF)3 (0.750 g, 2.00 mmol)
HL6 (0.707 g, 2.00 mmol), n-BuLi (1.60 M,
2.05 mmol), Cp*Li (0.284 g, 2.00 mmol)
and CrCl3(THF)3 (0.750 g, 2.00 mmol)
0.525 g, 1.16 mmol,
58.1%
Calcd for C25H35NOCrCl (453.00): C 66.28; H 7.79; N 3.09.
Found: C 66.12; H 7.88; N 3.05
0.572 g, 1.24 mmol,
62.6%
Calcd for C28H43NOCrCl (461.64): C 72.85; H 9.39; N 3.03.
Found: C 72.77; H 9.32; N 3.12
0.632 g, 1.37 mmol,
68.5%
Calcd for C28H43NOCrCl (461.64): C 72.85; H 9.39; N 3.03.
Found: C 72.53; H 9.47; N 3.12
0.644 g. 1.12 mmol,
56.0%
Calcd for C34H49NOCrCl (575.21): C 70.99; H 8.59; N 2.44.
Found: C 71.12; H 8.65; N 2.33
2-iPr-6-(CH NiPr)C6H3OH (HL1). To a stirred mixture of
3-isopropylsalicylaldehyde (1.64 g, 10.0 mmol) and anhydrous
MgSO4 (~1 g) in n-hexane (15 mL) was added isopropylamine
(1.20 g, 20.0 mmol) under nitrogen. After the mixture was heated at
reflux temperature for 8 h, the solvent was removed under reduced
pressure to give the crude imine product. The crude product was
purified by column chromatography on silica gel using petroleum
ether/ethyl acetate (95 : 5) as the eluent to afford pure 2-iPr-6-
(CH NiPr)C6H3OH (1.95 g, 9.50 mmol, 95.0%) as an orange oil.
1H NMR (CDCl3): d 1.27 (d, J = 9.6 Hz, 6H, CHMe2), 1.31 (d,
J = 9.6 Hz, 6H, CHMe2), 3.42 (h, J = 6.9 Hz, 1H, CHMe2), 3.56
(h, J = 6.3 Hz, 1H, CHMe2), 6.85 (t, J = 7.5 Hz, 1H, PhH), 7.09
(d, J = 7.5 Hz, 1H, PhH), 7.26 (d, J = 7.5 Hz, 1H, PhH), 8.36 (s,
1H, CH N), 14.10 (s, 1H, OH).
slowly added a suspension of Cp*Li (0.284 g, 2.00 mmol) in
THF (10 mL) at 0 ◦C. The mixture was allowed to warm to
room temperature and stirred overnight to get a blue solution.
In another flask, to a solution of 2-iPr-6-(CH NiPr)C6H3OH
(0.410 g, 2.00 mmol) in THF (15 mL) was added a solution of
n-BuLi (1.60 M, 2.05 mmol) in hexane by syringe at -78 ◦C. The
reaction mixture was allowed to warm to room temperature and
stirred for 1h, then added slowly to the above reaction mixture
◦
at -15 C. The obtained reaction mixture was allowed to warm
to room temperature and stirred overnight. During the reaction,
the color of the reaction mixture changes from blue to green.
Removal of the solvents under reduced pressure to give a dark-
green residue, followed by extraction with toluene (20 mL) to
remove the insoluble impurities. Pure product 1 was obtained
by recrystallization from CH2Cl2–n-hexane (v/v = 1 ~2 : 10) as
green crystals (0.540 g, 1.27 mmol, 63.5%). Anal. calcd for
C23H31NOCrCl (424.95): C 65.01; H 7.35; N 3.30. Found: C 65.16;
H 7.37; N 3.24.
The free ligands HL2, HL4, and HL6 were synthesized in
the same manner as HL1 with different starting materials. The
experimental data are listed in Table 6.
Complexes 2–6 were synthesized in the same manner as complex
1 with different starting materials. The experimental data are listed
in Table 7.
Cp*Cr[2-iPr-6-(CH NiPr)C6H3O]Cl (1). To a purple suspen-
sion of CrCl3(THF)3 (0.750 g, 2.00 mmol) in THF (20 mL) was
10192 | Dalton Trans., 2011, 40, 10184–10194
This journal is
The Royal Society of Chemistry 2011
©